-
101
-
102“...碩士 === 國立中興大學 === 化學系所 === 100 === Cancer is the leading cause of human death worldwide. Although...”
Get full text
Others -
103“.... However, drug resistance and adverse side-effects to chemotherapeutics in breast cancer patients...”
Get full text
Others -
104by Leung, Siu Ling“.... In reality, there are always pros and cons. Chemotherapeutics such as doxorubicin and paclitaxel can...”
Published 2013
Get full text
-
105
-
106by Stoiber, Patrick Moritz“...Factor Quinolinone Inhibitor 1 (FQI1) is a novel anti-cancer compound, having shown efficacy...”
Published 2021
Get full text
-
107“... as an oncogenic protein, recent increasing evidence suggests that this protein correlated with colorectal cancer...”
Get full text
Others -
108“...碩士 === 國立交通大學 === 分子醫學與生物工程研究所 === 104 === Lung cancer is leading case of cancers related death...”
Get full text
Others -
109“...-mediated sensitization to chemotherapeutic agents in cancer cells is unclear. Cisplatin is a commonly used...”
Get full text
Others -
110“... and affect human quality of life and lifespan. Lung cancer was the second most commonly estimated cancer case...”
Get full text
Others -
111by Walker, Kelcey Manae Becker“..., and research in this laboratory has developed selective AhR modulators (SAhRMs) for treatment of breast cancer...”
Published 2005
Get full text
Others -
112“...博士 === 高雄醫學大學 === 天然藥物研究所 === 101 === Breast cancer is the most common diagnosed cancer...”
Get full text
Others -
113“... to induce chemoresistance against chemotherapeutic agent cisplatin in SKOV-3 ovarian cancer cells. We found...”
Get full text
Others -
114“...碩士 === 國立陽明大學 === 傳統醫藥研究所 === 101 === Cancer is the leading cause of death in Taiwan. At present...”
Get full text
Others -
115by Colby, Aaron Henry“... are required for patients suffering from cancer-the second leading cause of death worldwide. Current...”
Published 2015
Get full text
-
116“...博士 === 國立中山大學 === 生物醫學研究所 === 101 === Breast cancer is the leading cause of death among Taiwanese...”
Get full text
Others -
117by 蔡佩樺“...碩士 === 國立交通大學 === 生物科技學系 === 103 === Small cell lung cancer (SCLC), exhibiting aggressive...”
Published 2014
Get full text
Others -
118by Yunes, Sarah Ann“... chemotherapeutic for multiple cancer types. In determining how FQI1 causes cancer cell death, it was previously...”
Published 2020
Get full text
-
119“... can serve as an effective chemotherapeutic target for treating clinical tubulin-binding agent...”
Get full text
Others -
120“... cancers such as DU-145, acting simultaneously as both a chemopreventive and a chemotherapeutic. ...”
Get full text
Others